vs
HARROW, INC.（HROW）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
HARROW, INC.的季度营收约是RE/MAX Holdings, Inc.的1.3倍（$89.1M vs $71.1M），HARROW, INC.净利率更高（7.4% vs 2.0%，领先5.4%），HARROW, INC.同比增速更快（33.3% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $8.1M），过去两年HARROW, INC.的营收复合增速更高（60.5% vs -4.7%）
哈罗健康（前身为Imprimis制药）是一家上市制药企业，总部位于美国田纳西州纳什维尔，深耕制药领域相关业务，在医药研发、生产及商业化方面拥有成熟的运营体系，产品及服务覆盖多个医疗需求场景。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
HROW vs RMAX — 直观对比
营收规模更大
HROW
是对方的1.3倍
$71.1M
营收增速更快
HROW
高出35.1%
-1.8%
净利率更高
HROW
高出5.4%
2.0%
自由现金流更多
RMAX
多$25.4M
$8.1M
两年增速更快
HROW
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.1M | $71.1M |
| 净利润 | $6.6M | $1.4M |
| 毛利率 | 79.3% | — |
| 营业利润率 | 17.5% | 13.1% |
| 净利率 | 7.4% | 2.0% |
| 营收同比 | 33.3% | -1.8% |
| 净利润同比 | -2.2% | -75.2% |
| 每股收益（稀释后） | $0.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HROWRMAX
| Q4 25 | $89.1M | $71.1M | ||
| Q3 25 | $71.6M | $73.2M | ||
| Q2 25 | $63.7M | $72.8M | ||
| Q1 25 | $47.8M | $74.5M | ||
| Q4 24 | $66.8M | $72.5M | ||
| Q3 24 | $49.3M | $78.5M | ||
| Q2 24 | $48.9M | $78.5M | ||
| Q1 24 | $34.6M | $78.3M |
净利润HROWRMAX
| Q4 25 | $6.6M | $1.4M | ||
| Q3 25 | $1.0M | $4.0M | ||
| Q2 25 | $5.0M | $4.7M | ||
| Q1 25 | $-17.8M | $-2.0M | ||
| Q4 24 | $6.8M | $5.8M | ||
| Q3 24 | $-4.2M | $966.0K | ||
| Q2 24 | $-6.5M | $3.7M | ||
| Q1 24 | $-13.6M | $-3.4M |
毛利率HROWRMAX
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
营业利润率HROWRMAX
| Q4 25 | 17.5% | 13.1% | ||
| Q3 25 | 20.6% | 25.0% | ||
| Q2 25 | 17.9% | 19.3% | ||
| Q1 25 | -23.5% | 7.2% | ||
| Q4 24 | 19.3% | 5.9% | ||
| Q3 24 | 2.7% | 19.4% | ||
| Q2 24 | 3.1% | 20.6% | ||
| Q1 24 | -20.0% | 5.8% |
净利率HROWRMAX
| Q4 25 | 7.4% | 2.0% | ||
| Q3 25 | 1.4% | 5.4% | ||
| Q2 25 | 7.8% | 6.4% | ||
| Q1 25 | -37.2% | -2.6% | ||
| Q4 24 | 10.1% | 8.0% | ||
| Q3 24 | -8.6% | 1.2% | ||
| Q2 24 | -13.2% | 4.7% | ||
| Q1 24 | -39.2% | -4.3% |
每股收益（稀释后）HROWRMAX
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $-0.50 | — | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $-0.38 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $118.7M |
| 总债务越低越好 | $250.0M | $432.2M |
| 股东权益账面价值 | $52.4M | $452.4M |
| 总资产 | $399.5M | $582.5M |
| 负债/权益比越低杠杆越低 | 4.77× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资HROWRMAX
| Q4 25 | $72.9M | $118.7M | ||
| Q3 25 | $74.3M | $107.5M | ||
| Q2 25 | $53.0M | $94.3M | ||
| Q1 25 | $66.7M | $89.1M | ||
| Q4 24 | $47.2M | $96.6M | ||
| Q3 24 | $72.6M | $83.8M | ||
| Q2 24 | $71.0M | $66.1M | ||
| Q1 24 | $76.0M | $82.1M |
总债务HROWRMAX
| Q4 25 | $250.0M | $432.2M | ||
| Q3 25 | $347.2M | $433.3M | ||
| Q2 25 | $250.6M | $434.4M | ||
| Q1 25 | $256.9M | $435.3M | ||
| Q4 24 | $262.7M | $436.2M | ||
| Q3 24 | $230.7M | $437.2M | ||
| Q2 24 | $236.3M | $438.1M | ||
| Q1 24 | $243.4M | $439.0M |
股东权益HROWRMAX
| Q4 25 | $52.4M | $452.4M | ||
| Q3 25 | $47.0M | $448.1M | ||
| Q2 25 | $49.7M | $442.4M | ||
| Q1 25 | $56.5M | $433.5M | ||
| Q4 24 | $69.7M | $429.5M | ||
| Q3 24 | $58.0M | $423.1M | ||
| Q2 24 | $58.5M | $418.4M | ||
| Q1 24 | $60.6M | $412.0M |
总资产HROWRMAX
| Q4 25 | $399.5M | $582.5M | ||
| Q3 25 | $363.1M | $582.2M | ||
| Q2 25 | $345.0M | $574.8M | ||
| Q1 25 | $364.2M | $571.4M | ||
| Q4 24 | $389.0M | $581.6M | ||
| Q3 24 | $351.5M | $578.6M | ||
| Q2 24 | $306.6M | $571.4M | ||
| Q1 24 | $295.5M | $566.7M |
负债/权益比HROWRMAX
| Q4 25 | 4.77× | 0.96× | ||
| Q3 25 | 7.39× | 0.97× | ||
| Q2 25 | 5.05× | 0.98× | ||
| Q1 25 | 4.55× | 1.00× | ||
| Q4 24 | 3.77× | 1.02× | ||
| Q3 24 | 3.98× | 1.03× | ||
| Q2 24 | 4.04× | 1.05× | ||
| Q1 24 | 4.02× | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.4M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $33.5M |
| 自由现金流率自由现金流/营收 | 9.1% | 47.1% |
| 资本支出强度资本支出/营收 | 0.4% | 10.4% |
| 现金转化率经营现金流/净利润 | 1.27× | 28.39× |
| 过去12个月自由现金流最近4个季度 | $43.0M | $56.8M |
8季度趋势，按日历期对齐
经营现金流HROWRMAX
| Q4 25 | $8.4M | $40.9M | ||
| Q3 25 | $16.6M | $17.7M | ||
| Q2 25 | $-803.0K | $4.6M | ||
| Q1 25 | $19.7M | $5.7M | ||
| Q4 24 | $-17.8M | $59.7M | ||
| Q3 24 | $3.0M | $17.6M | ||
| Q2 24 | $-2.7M | $15.9M | ||
| Q1 24 | $-4.6M | $9.4M |
自由现金流HROWRMAX
| Q4 25 | $8.1M | $33.5M | ||
| Q3 25 | $16.4M | $16.4M | ||
| Q2 25 | $-969.0K | $2.9M | ||
| Q1 25 | $19.5M | $4.0M | ||
| Q4 24 | $-18.3M | $53.0M | ||
| Q3 24 | $2.3M | $16.3M | ||
| Q2 24 | $-3.1M | $14.0M | ||
| Q1 24 | $-4.7M | $6.8M |
自由现金流率HROWRMAX
| Q4 25 | 9.1% | 47.1% | ||
| Q3 25 | 22.9% | 22.4% | ||
| Q2 25 | -1.5% | 4.0% | ||
| Q1 25 | 40.8% | 5.3% | ||
| Q4 24 | -27.4% | 73.2% | ||
| Q3 24 | 4.8% | 20.8% | ||
| Q2 24 | -6.3% | 17.8% | ||
| Q1 24 | -13.6% | 8.6% |
资本支出强度HROWRMAX
| Q4 25 | 0.4% | 10.4% | ||
| Q3 25 | 0.3% | 1.8% | ||
| Q2 25 | 0.3% | 2.2% | ||
| Q1 25 | 0.4% | 2.3% | ||
| Q4 24 | 0.8% | 9.1% | ||
| Q3 24 | 1.2% | 1.7% | ||
| Q2 24 | 0.7% | 2.4% | ||
| Q1 24 | 0.3% | 3.3% |
现金转化率HROWRMAX
| Q4 25 | 1.27× | 28.39× | ||
| Q3 25 | 16.26× | 4.45× | ||
| Q2 25 | -0.16× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HROW
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
